Newron Pharmaceuticals newron.com


Public list: Pharma Startups (4740) Rare Diseases (230) Neuroscience Startups (942)

Newron Pharmaceuticals is a biopharmaceutical company focused on novel therapies for diseases of the Central Nervous System and pain. Newron is undertaking phase III trials with safinamide for the treatment of Parkinson's disease (PD) in conjunction with its partner, Merck Serono, which has exclusive worldwide rights to develop, manufacture and commercialize the compound in PD, Alzheimeru00b4s disease, and other therapeutic applications. Newron recently reported excellent results for its compoun...Show all

Newron Pharmaceuticals is a biopharmaceutical company focused on novel therapies for diseases of the Central Nervous System and pain. Newron is undertaking phase III trials with safinamide for the treatment of Parkinson's disease (PD) in conjunction ...Show all

Company (IPO / Went public)

Phone: +39 02 610 3461

Fax: +39 02 610 34654

via Ludovico Ariosto 21

20091
Italy

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Newron Pharmaceuticals $36M Nov 27, 2006
See all 51 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Newron Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 5 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 51 competitors